The undifferentiated enzymic composition of human fetal lung and pulmonary tumors.
The concentrations of 16 to 21 enzymes, representing various metabolic pathways, have been determined in human adult, fetal, and neoplastic lung. At midgestation, 12 enzymes (among them, several that metabolize amino acids) were above their adult values while 3 other enzymes were still at low concentrations. These signs of biochemical immaturity are contrasted and compared with those in fetal human liver and rat lung. The enzymic composition of the 11 human pulmonary tumors studied resembled that of the normal fetal lungs closely; the same 12 enzymes were elevated and the same 2 were decreased (compared to nonneoplastic adult lung) in both. The characteristic abnormality in the overall pattern of enzymes, in the concentrations of individual ones, and in the quality of pyrroline-5-carboxylate reductase was clearly evident in both primary and metastatic tumors. The mean concentrations of 10 enzymes in the tumors were significantly different (higher or lower) from those in the control lungs (p less than 0.001 to less than 0.05). The best markers of neoplasticity were thymidine kinase, peptidyl proline hydroxylase, phosphoserine phosphatase, hexokinase, and pyrroline-5-carboxylate reductase. The results demonstrate that quantification of a small battery of enzymes, none of them tissue specific, can distinguish adult human lung from its neoplasms.
D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000032:analysis; D000410:Alanine Transaminase / Q000032:analysis; D000429:Alcohol Oxidoreductases / Q000032:analysis; D001119:Arginase / Q000032:analysis; D001219:Aspartate Aminotransferases / Q000032:analysis; D002268:Carboxypeptidases / Q000032:analysis; D004093:Dihydropteridine Reductase / Q000032:analysis; D005865:Gestational Age; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D005969:Glutamate Dehydrogenase / Q000032:analysis; D005945:Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) / Q000032:analysis; D006593:Hexokinase / Q000032:analysis; D066298:In Vitro Techniques; D008168:Lung / Q000196:embryology / Q000201:enzymology*; D008175:Lung Neoplasms / Q000201:enzymology*; D008291:Malate Dehydrogenase / Q000032:analysis; D009954:Ornithine Carbamoyltransferase / Q000032:analysis; D009953:Ornithine-Oxo-Acid Transaminase / Q000032:analysis; D010651:Phenylalanine Hydroxylase / Q000032:analysis; D010744:Phosphoric Monoester Hydrolases / Q000032:analysis; D011762:Pyrroline Carboxylate Reductases / Q000032:analysis; D013937:Thymidine Kinase / Q000032:analysis
D000429:Alcohol Oxidoreductases; D008291:Malate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D010651:Phenylalanine Hydroxylase; D005969:Glutamate Dehydrogenase; D011762:Pyrroline Carboxylate Reductases; D004093:Dihydropteridine Reductase; D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; D009954:Ornithine Carbamoyltransferase; D001219:Aspartate Aminotransferases; D009953:Ornithine-Oxo-Acid Transaminase; D005945:Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); D000410:Alanine Transaminase; D006593:Hexokinase; D013937:Thymidine Kinase; D010744:Phosphoric Monoester Hydrolases; D002268:Carboxypeptidases; D001119:Arginase